<code id='69937D14BA'></code><style id='69937D14BA'></style>
    • <acronym id='69937D14BA'></acronym>
      <center id='69937D14BA'><center id='69937D14BA'><tfoot id='69937D14BA'></tfoot></center><abbr id='69937D14BA'><dir id='69937D14BA'><tfoot id='69937D14BA'></tfoot><noframes id='69937D14BA'>

    • <optgroup id='69937D14BA'><strike id='69937D14BA'><sup id='69937D14BA'></sup></strike><code id='69937D14BA'></code></optgroup>
        1. <b id='69937D14BA'><label id='69937D14BA'><select id='69937D14BA'><dt id='69937D14BA'><span id='69937D14BA'></span></dt></select></label></b><u id='69937D14BA'></u>
          <i id='69937D14BA'><strike id='69937D14BA'><tt id='69937D14BA'><pre id='69937D14BA'></pre></tt></strike></i>

          knowledge

          knowledge

          author:fashion    Page View:9573
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          FDA approves world's first CRISPR
          FDA approves world's first CRISPR

          ChristineKao/STATTheFoodandDrugAdministrationonFridayapprovedtheworld’sfirstmedicinebasedonCRISPRgen

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Sanofi says it has 12 blockbusters on the way. Will investors believe it?

          SanofiCEOPaulHudsonCourtesySanofiNEWYORK—ThetopexecutivesatFrenchdruggiantSanofionWednesdaydefendedt